These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29460924)

  • 1. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.
    Subramanian V; Kattan MW
    Nat Rev Urol; 2018 Apr; 15(4):208-209. PubMed ID: 29460924
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
    Zürcher S
    Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
    [No Abstract]   [Full Text] [Related]  

  • 4. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.
    Lewis R; Hornberger B
    JAAPA; 2017 Aug; 30(8):51-54. PubMed ID: 28742748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer screening.
    Sikaris K
    Pathology; 2012 Feb; 44(2):99-109. PubMed ID: 22198258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
    Rodriguez JF; Eggener SE
    Radiol Clin North Am; 2018 Mar; 56(2):187-196. PubMed ID: 29420975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indirect consequences of PSA testing for prostate cancer screening].
    Naïmi R; Senglet M; De Gorski A; Kherad O
    Rev Med Suisse; 2020 Feb; 16(680):275-277. PubMed ID: 32022494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised status of PSA testing in the early detection and treatment of prostate cancer.
    Lamb DS; Delahunt B; Nacey JN
    N Z Med J; 2011 Nov; 124(1345):13-5. PubMed ID: 22072161
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.
    Wilt TJ; Scardino PT; Carlsson SV; Basch E
    J Natl Cancer Inst; 2014 Mar; 106(3):dju010. PubMed ID: 24594482
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for active surveillance for low risk prostate cancer.
    Drost FH; Roobol MJ
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries for patients. Screening smarter, not harder, for prostate cancer.
    Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative prostate cancer screening strategies.
    Labrecque M; Aprikian A
    Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative prostate cancer screening strategies--in response.
    Gulati R; Etzioni R
    Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
    [No Abstract]   [Full Text] [Related]  

  • 19. Probability, uncertainty, and prostate cancer.
    Concato J
    Ann Intern Med; 2013 Feb; 158(3):211-212. PubMed ID: 23381041
    [No Abstract]   [Full Text] [Related]  

  • 20. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
    Klotz L
    Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.